May 20, 2022
Heart failure Pipeline

Heart failure Pipeline

Heart failure, also known as congestive heart failure refers to the condition when heart is not able to pump adequate blood to the body. In the absence of sufficient blood flow, all the major body functions are disrupted. Certain conditions, such as narrowed arteries in the heart (coronary artery disease) or high blood pressure, gradually leave the heart too weak or stiff to fill and pump efficiently. Heart failure can be diagnosed based on the medical and family history, a physical exam, and test results. Treating heart failure depends on the severity of the condition. Diagnostic tests include: electrocardiogram, chest X-Ray, echocardiography etc. Treatments usually include heart-healthy lifestyle changes, medicines, and ongoing care.

DelveInsight’s, “Heart failure Pipeline Insight, 2022” report provides comprehensive insights about 100+ companies and 100+ pipeline drugs in Heart failure pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.

Request for Free Sample Report: https://www.delveinsight.com/sample-request/heart-failure-pipeline-insight

Heart failure Key Players:

  • Bayer HealthCare Pharmaceuticals
  • Ionis Pharmaceuticals
  • Heartseed Inc.
  • AstraZeneca
  • Amgen
  • Sardocor Corp.
  • Intra-Cellular Therapies
  • Bristol Myers Squibb
  • Eli Lilly and Company
  • Palatin Technologies
  • Cardiora
  • Zensun Sci. & Tech. Co., Ltd.
  • Biopeutics Co., Ltd
  • Innolife Co., Ltd.
  • SQ Innovation
  • scPharmaceuticals
  • Mesoblast, Inc
  • PhaseBio Pharmaceuticals
  • Salubris Biotherapeutics Inc
  • Actelion Pharmaceuticals
  • Torrent Pharmaceuticals Limited
  • Novo Nordisk A/S
  • Shanghai Hongyitang Biopharmaceutical Technology Co. Ltd.
  • Merck Sharp & Dohme Corp.
  • Cardior Pharmaceuticals GmbH
  • Pfizer
  • MyoKardia, Inc.
  • TransThera Biosciences Co., Ltd
  • Acceleron Pharma Inc.
  • Asklepios Biopharmaceutical, Inc.
  • And Many Others

DelveInsight’s Heart failure report covers around 10+ products under different phases of clinical development like:

  • Late-stage products (Phase III)
  • Mid-stage products (Phase II and Phase I/II)
  • Early-stage products (Phase I/II and Phase I) along with the details of
  • Pre-clinical and Discovery stage candidates
  • Discontinued & Inactive candidates

Request for Free Sample Report: https://www.delveinsight.com/sample-request/heart-failure-pipeline-insight

Some of Heart failure Therapies:

  • BAY-1753011
  • Omecamtiv Mecarbil
  • ACRX-100
  • GSK2798745
  • LMI 1195-101
  • And Many Others

Request for Free Sample Report: https://www.delveinsight.com/sample-request/heart-failure-pipeline-insight

Current Heart failure Treatment Scenario and Heart failure Emerging Therapies:

  • How many companies are developing Heart failure drugs?
  • How many Heart failure drugs are developed by each company?
  • How many emerging drugs are in mid-stage, and late-stage of development for the treatment of Heart failure?
  • What are the key collaborations (Industry–Industry, Industry–Academia), Mergers and acquisitions, licensing activities related to the Heart failure therapeutics?
  • What are the recent trends, drug types and novel technologies developed to overcome the limitation of existing therapies?
  • What are the clinical studies going on for Heart failure and their status?
  • What are the key designations that have been granted to the emerging drugs?

Request for Free Sample Report: https://www.delveinsight.com/sample-request/heart-failure-pipeline-insight

Table of Contents:

Introduction

Executive Summary

Heart failure: Overview

Pipeline Therapeutics

  • Comparative Analysis

Therapeutic Assessment

Heart failure – DelveInsight’s Analytical Perspective

In-depth Commercial Assessment

Heart failure Collaboration Deals

Late Stage Products (Phase III)

  • Comparative Analysis

Drug profiles in the detailed report…..

Mid Stage Products (Phase II)

  • Comparative Analysis

Drug profiles in the detailed report…..

Pre-clinical and Discovery Stage Products

Drug profiles in the detailed report…..

Inactive Products

  • Comparative Analysis

Heart failure Key Companies

Heart failure Key Products

Heart failure- Unmet Needs

Heart failure- Market Drivers and Barriers

Heart failure- Future Perspectives and Conclusion

Heart failure Analyst Views

Heart failure Key Companies

Appendix

Request for Detailed TOC: https://www.delveinsight.com/sample-request/heart-failure-pipeline-insight

Get in touch with our Business executive for Rich and Deep Healthcare Consulting Solutions

DelveInsight’s Competitive Intelligence Service includes a multidimensional coverage, helping to keep track of competitors and gain traction in the dynamic market by overcoming the challenges and expediting business growth through a strategic and tactical approach.

Some of Newly Launched Report: 

Related Blogs:

About Delveinsight: 

DelveInsight Business Research is a leading Market Research, and Business Consultant focused purely on Healthcare. It helps pharma companies by providing them with end-to-end services to solve their business problems.

Get hold of all the Pharma and healthcare market research reports on our market research subscription-based platform PharmDelve.

Media Contact

Company Name: DelveInsight Business Research LLP

Contact Person: Ankit Nigam

Email: [email protected]

Phone: +19193216187

City: Albany

State: New York

Country: United States

Website: https://www.delveinsight.com

Connect With Us at:

LinkedIn | Facebook | Twitter

Request for Free Sample Report: https://www.delveinsight.com/sample-request/heart-failure-pipeline-insight

Leave a Reply

Your email address will not be published.